Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus
Clinical trial NCT01171976 · COMPLETED
Trial details
- NCT number
- NCT01171976
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-04-01
- Enrollment
- 373
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.